Skip to main content

Technologies

23 results found
Pharmaceuticals / Nutraceuticals
Technologies
ID: 2019-051 Researchers at BYU have discovered antioxidants that are significantly more effective than current available antioxidants.
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2018-057 and 2014-098 BYU has discovered monocytes in the blood that provide a direct correlation to dopamine levels in the brain.
Technologies
ID: 2018-037 This technology is based on the use of phages infecting a bacteria and, as a byproduct of phage infection, antimicrobial components are released that can kill nearby infectious pathogens
Technologies
ID: 2018-035 The Paper Lateral Flow Immunoassay (pLFI) technique improves upon the traditional LFI, commonly recognized as diagnostic blood tests or pregnancy tests, reducing the costs of materials and precision in manufacturing.
Technologies
ID: 2017-072 Tight junctions between membranes in the human body are responsible for limiting access through tissues to organs the rest of the interior of the body for promising therapies.
Technologies
ID: 2017-044 A bio-assay for rapid screening and detection of nuclear hormone receptor modulators (see also 2016-053)
Technologies
ID: 2017-039 Novel Drug for Thalassemia & Hemochromatosis (Iron Overload)
Technologies
ID: 2017-029 Room-sized scanned-aperture holographic video display with low complexity